SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?

Gut microbiome alterations may play a paramount role in determining the clinical outcome of clinical COVID-19 with underlying comorbid conditions like T2D, cardiovascular disorders, obesity, etc. Research is warranted to manipulate the profile of gut microbiota in COVID-19 by employing combinatorial...

Descripción completa

Detalles Bibliográficos
Autores principales: Chattopadhyay, Indranil, Shankar, Esaki M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006403/
https://www.ncbi.nlm.nih.gov/pubmed/33791231
http://dx.doi.org/10.3389/fcimb.2021.590874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006403/
https://www.ncbi.nlm.nih.gov/pubmed/33791231
http://dx.doi.org/10.3389/fcimb.2021.590874

Ejemplares similares